September 15, 2009 -
September 15, 2009 ICAAC: Once-Daily Isentress as Good as Twice-Daily? People who switched from a protease inhibitor (PI) to Isentress (raltegravir) did well regardless of whether they switched to ... by the National AIDS Treatment Advocacy Project (NATAP). Isentress is currently the only approved drug in a ... treatment for the first time. To determine whether Isentress could be used twice daily, researchers conducted ...
http://www.aidsmeds.com/articles/hiv_isentress_raltegravir_1667_17251.shtml
July 31, 2009 -
David Evans -
July 31, 2009 Isentress Without a Protease Inhibitor Is Effective for Treatment ... not be necessary to combine the integrase inhibitor Isentress (raltegravir) with a protease inhibitor (PI) in treatment experienced ... and Prevention in Cape Town. People on an Isentress regimen without a PI maintained undetectable virus levels ... the same rate as those on a PI. Raltegravir has proved to be one of the ...
http://www.aidsmeds.com/articles/hiv_isentress_raltegravir_1667_17017.shtml
July 22, 2009 -
Tim Horn -
... 2009 By Tim Horn A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir) boosted Prezista (darunavir ... HIV Pathogenesis, Treatment and Prevention in Cape Town. Isentress, Intelence and Prezista are three of the newest ... for treatment-experienced people living with HIV; both Isentress and Prezista are now also approved for treatment ... study enrolled 103 HIV-positive patients to take Isentress, Intelence and Norvir-boosted Prezista with an ...
http://www.aidsmeds.com/articles/hiv_trio_isentress_2351_16955.shtml
July 22, 2009 -
Tim Horn -
... Patients by Tim Horn A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir) boosted Prezista (darunavir ... HIV Pathogenesis, Treatment and Prevention in Cape Town. Isentress, Intelence and Prezista are three of the newest ... for treatment-experienced people living with HIV; both Isentress and Prezista are now also approved for treatment ... study enrolled 103 HIV-positive patients to take Isentress, Intelence and Norvir-boosted Prezista with an ...
http://www.aidsmeds.com/articles/hiv_trio_isentress_1667_16955.shtml
July 21, 2009 -
Tim Horn -
Isentress Going Strong After Three Years in Treatment Starters ... clinical trial show that Merck s integrase inhibitor Isentress (raltegravir) works just as well as mainstay therapy efavirenz ... HIV Pathogenesis, Treatment and Prevention in Cape Town. Isentress was originally approved for treatment-experienced people living ... 004, one of the studies used to support Isentress s approval for treatment-naïve individuals, were ...
http://www.aidsmeds.com/articles/hiv_isentress_raltegravir_2351_16948.shtml
July 21, 2009 -
Tim Horn -
... day and without a boosting agent; Merck s Isentress (raltegravir) currently requires twice-daily dosing, whereas Gilead s ... work against HIV that has become resistant to Isentress or elvitegravir. The study reviewed at IAS by ... somewhat sly comparison with other integrase inhibitors specifically Isentress (raltegravir) and elvitegravir, neither of which were used ...
http://www.aidsmeds.com/articles/hiv_gsk1349572_integrase_2351_16953.shtml
July 21, 2009 -
Tim Horn -
... day and without a boosting agent; Merck s Isentress (raltegravir) currently requires twice-daily dosing, whereas Gilead s ... work against HIV that has become resistant to Isentress or elvitegravir. The study reviewed at IAS by ... somewhat sly comparison with other integrase inhibitors specifically Isentress (raltegravir) and elvitegravir, neither of which were used ...
http://www.aidsmeds.com/articles/hiv_gsk1349572_integrase_1667_16953.shtml
July 21, 2009 -
Tim Horn -
July 21, 2009 Isentress Going Strong After Three Years in Treatment Starters ... clinical trial show that Merck s integrase inhibitor Isentress (raltegravir) works just as well as mainstay therapy efavirenz ... HIV Pathogenesis, Treatment and Prevention in Cape Town. Isentress was originally approved for treatment-experienced people living ... 004, one of the studies used to support Isentress s approval for treatment-naïve individuals, were ...
http://www.aidsmeds.com/articles/hiv_isentress_raltegravir_1667_16948.shtml
July 10, 2009 -
July 10, 2009 Isentress Gets FDA Approval for Treatment Newbies Merck & Co ... Drug Administration (FDA) to market its integrase inhibitor, Isentress (raltegravir), for people who have never taken HIV treatment. Isentress was previously approved only to treat people who ... 48 week data from the STARTMRK study comparing Isentress and Truvada (tenofovir plus emtricitabine) with Sustiva ( ...
http://www.aidsmeds.com/articles/hiv_isentress_raltegravir_1667_16899.shtml
April 21, 2009 -
April 21, 2009 Isentress s Prevention Potential The integrase inhibitor Isentress (raltegravir), when taken by either HIV-negative or HIV ... prevention purposes. To determine genital tract distribution with Isentress, Amanda Jones, PharmD, from the University of North ... her colleagues studied blood and genital levels of Isentress in seven HIV-negative women. All of ...
http://www.aidsmeds.com/articles/hiv_prevention_isentress_1667_16493.shtml
